PTHS
AMEX
$27.26
Channel Therapeutics Corporation (PTHS)
Pelthos Therapeutics Inc., a bio-pharmaceutical company, develops and commercializes therapeutic products to help patients with unmet treatment burdens. The company is headquartered in Durham, North Carolina.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $57.71 (+111.70%)
Market Cap
$92M
Free Cash Flow Yield
-38.60%
Beta (5Y)
1.05
Price Chart
Valuation
Market Cap$92M
P/S3.41
P/B2.52
Profitability
Total Revenue (TTM)$28M
Gross Profit (TTM)$21M
EBITDA-$42M
Profit Margin-93.9%
Operating Margin-120%
EPS-$38.97
Financial Health
Free Cash Flow Yield-38.60%
Growth & Risk
Beta (5Y)1.05
Sharpe Ratio0.61